ViaDerma, Inc. (VDRM)

ViaDerma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2017	FY 2016	FY 2015	FY 2011	FY 2010
Period Ending	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2011	Dec 31, 2010
Net Income	-1.52	-0.12	0.03	2.67	4.51
Depreciation & Amortization	0	0	0	2.81	1.56
Other Amortization	0.3	0.15	0.02	-	0.86
Loss (Gain) From Sale of Assets	-	-	-	0	0
Stock-Based Compensation	0.33	-	0.04	-	-
Other Operating Activities	0.61	0.06	-0.05	-	-
Change in Accounts Receivable	-0.02	-0.2	-0.17	0.62	0.09
Change in Inventory	-0.02	-0	0	0.67	0.43
Change in Accounts Payable	-	-	-	-0.15	-0.31
Change in Income Taxes	-	-	-	-0.3	-0.15
Change in Other Net Operating Assets	0.15	0.1	0.12	-0.26	0.79
Operating Cash Flow	-0.17	-0.01	-0.01	6.05	7.78
Operating Cash Flow Growth	-	-	-	-22.15%	135.09%
Capital Expenditures	-	-	-	-9.43	-7.13
Sale of Property, Plant & Equipment	-	-	-	0	0
Investing Cash Flow	-	-	-	-9.43	-7.12
Short-Term Debt Issued	0.17	0.02	0.01	1.8	1.48
Long-Term Debt Issued	-	-	-	3.1	1.03
Total Debt Issued	0.17	0.02	0.01	4.9	2.51
Short-Term Debt Repaid	-	-	-	-1.74	-1.82
Long-Term Debt Repaid	-	-	-	-0.2	-1.13
Total Debt Repaid	-	-	-	-1.95	-2.95
Net Debt Issued (Repaid)	0.17	0.02	0.01	2.95	-0.45
Financing Cash Flow	0.17	0.02	0.01	2.95	-0.45
Foreign Exchange Rate Adjustments	-	-	-	0.03	-0.01
Net Cash Flow	0	0.01	-0	-0.39	0.2
Free Cash Flow	-0.17	-0.01	-0.01	-3.38	0.65
Free Cash Flow Margin	-374.49%	-4.79%	-5.83%	-17.77%	2.43%
Free Cash Flow Per Share	-	-	-	-24.60	4.74
Cash Interest Paid	-	-	-	0.41	0.19
Cash Income Tax Paid	-	-	-	1.18	2.15
Levered Free Cash Flow	0.69	-0.2	-	-4.46	-1.11
Unlevered Free Cash Flow	0.63	-0.2	-	-4.15	-0.32
Change in Working Capital	0.11	-0.1	-0.05	0.57	0.85

Updated May 3, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.